Drug profile · INN
elapegademase
REVCOVI
elapegademase (REVCOVI) is a 2'-deoxyadenosine hydrolytic enzyme.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — elapegademase
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
elapegademase (REVCOVI) is a 2'-deoxyadenosine hydrolytic enzyme.
Key facts
INN elapegademase
Brand REVCOVI
Mechanism 2'-deoxyadenosine hydrolytic enzyme
Target 2'-deoxyadenosine
Mechanism of action
2'-deoxyadenosine hydrolytic enzyme
Primary target: 2'-deoxyadenosine
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is elapegademase?
elapegademase (REVCOVI) is a 2'-deoxyadenosine hydrolytic enzyme.
What is the brand name for elapegademase?
REVCOVI is a marketed brand name for elapegademase. Check FDA Drugs@FDA for the current US label holder and prescribing information.